Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00100425 · ClinicalTrials.gov registry record · NA

Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome

A NA study, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase

NCT00100425: Completed NA study, sponsored by US Department of Veterans Affairs.

NCT00100425 is a NA study that has completed, run by US Department of Veterans Affairs. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00100425, a NA study, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase

Study Summary

The purpose of this study is to provide new information and to determine which kinds of brief, tolerable, experimental pain are affected by the drugs being studied in patients with irritable bowel syndrome, a disease that causes chronic abdominal pain. The effects of dextromethorphan, naloxone, and fentanyl on experimental pain stimuli will be tested in these studies to better understand what causes irritable bowel syndrome.

Interventions

  • PROCEDURE Viceral Perception Testing

Trial Details

FieldValue
Start Date 2000-09
Phase NA
US Department of Veterans Affairs

632 total trials

What the finished NCT00100425 record still lists

NCT00100425 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 0 conditions, and to 1 intervention - of which Viceral Perception Testing is the first listed.

NCT00100425 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00100425 about?

NCT00100425 is a clinical study titled "Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome". The purpose of this study is to provide new information and to determine which kinds of brief, tolerable, experimental pain are affected by the drugs being studied in patients with irritable bowel syndrome, a disease that causes chronic abdominal pain. The effects of dextromethorphan, naloxone, and ...

What is the current status of trial NCT00100425?

This trial is currently completed. It is a NA study. The study started on 2000-09.

What interventions are being tested in trial NCT00100425?

The interventions under investigation include: Viceral Perception Testing (PROCEDURE).

Who is sponsoring clinical trial NCT00100425?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00100425, the US trial registry maintained by the National Library of Medicine. NCT00100425 (unsized enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.